1. The nuclear-myofibrilar (800g pellet) fraction of the uterus from immature (22-23 days old) rats not exposed to oestrogen exhibits saturable binding of oestradiol. This nuclear binding capacity represents approximately 10% of that of the cytosol fraction (approx. 3.5fmol/ug of DNA). The predominant part (0.3 fmol/,ug of DNA) of the nuclear binding sites are present in the residual pellet after extraction with 0.5M-KCI. 2. By using an exchange technique in vitro, determinations of the nuclear binding sites have been carried out after administration of 1 ug of oestradiol in vivo. Within 0.5h after the hormone injection, the concentration of nuclear binding sites increased to approx. 0.4fmol/,ug of DNA in the 0.5M-KCl-extractable fraction, and to approx. 1.2fmol/cpg of DNA in the residual fraction. Meanwhile the cytosol oestrogen-receptor concentration decreased to approx. 10% of its initial value. In the following period from 0.5h after the oestradiol injection onwards, the concentration of nuclear oestrogen receptors decreased with halflife values of approx. 140 and 200min for the KCI (0.5M)-extractable and residual form respectively. At the same time, the cytosol receptor concentration increased to reach approx. 50% of the initial value by 6h. This increase could not be blocked by cycloheximide. The initial concentration of cytosol receptor was restored approx. 11 h after the injection and the increase during the 6-l1 h period was sensitive to cycloheximide inhibition, suggesting protein-synthesis-dependence of the process. 3. With the (more) physiological dose of oestradiol (O.1,ug), the decrease of the cytosol receptor was only 50% by 4h and this was followed by a period (up to 12h after injection) during which the initial concentration was restored. During this period the increase of the receptor can be blocked by cycloheximide.
1. The nuclear-myofibrilar (800g pellet) fraction of the uterus from immature (22-23 days old) rats not exposed to oestrogen exhibits saturable binding of oestradiol. This nuclear binding capacity represents approximately 10% of that of the cytosol fraction (approx. 3.5fmol/ug of DNA). The predominant part (0.3 fmol/,ug of DNA) of the nuclear binding sites are present in the residual pellet after extraction with 0.5M-KCI. 2. By using an exchange technique in vitro, determinations of the nuclear binding sites have been carried out after administration of 1 ug of oestradiol in vivo. Within 0.5h after the hormone injection, the concentration of nuclear binding sites increased to approx. 0.4fmol/,ug of DNA in the 0.5M-KCl-extractable fraction, and to approx. 1.2fmol/cpg of DNA in the residual fraction. Meanwhile the cytosol oestrogen-receptor concentration decreased to approx. 10% of its initial value. In the following period from 0.5h after the oestradiol injection onwards, the concentration of nuclear oestrogen receptors decreased with halflife values of approx. 140 and 200min for the KCI (0.5M)-extractable and residual form respectively. At the same time, the cytosol receptor concentration increased to reach approx. 50% of the initial value by 6h. This increase could not be blocked by cycloheximide. The initial concentration of cytosol receptor was restored approx. 11 h after the injection and the increase during the 6-l1 h period was sensitive to cycloheximide inhibition, suggesting protein-synthesis-dependence of the process. 3. With the (more) physiological dose of oestradiol (O.1,ug) , the decrease of the cytosol receptor was only 50% by 4h and this was followed by a period (up to 12h after injection) during which the initial concentration was restored. During this period the increase of the receptor can be blocked by cycloheximide.
Injection of oestradiol into immature rats rapidly leads to a decrease of the concentration of uterine cytosol high-affinity oestrogen-binding sites (receptor) and to an increase of the nuclear oestrogen receptor concentration (e.g. per total uterus). With the so-called physiological dose of the hormone (0.1lug/animal), the decrease of the receptor content 4h after injection is approx. 50% of the initial value (Sarff & Gorski, 1971) , and this loss is only partly accounted for by the increase of the nuclear receptor concentration (Feherty, 1972; Milgrom et al., 1973) . The cytosol receptor concentration is restored during the following period reaching approx. 1.5 times its initial value by 24h after the injection; this process is inhibited by cycloheximide (Jensen et al., 1969; Sarff & Gorski, 1971) . The mechanism by which the cytoplasmic oestrogen receptor concentration is restored was examined by Sarff & Gorski (1971) whose results suggested that virtually all the protein * Postal address: Lab Hormones, F94270-Bicetre, France. Vol. 146 synthesis necessary is completed within approx. 4h after administration of oestradiol (0.1 ccg).
A different situation is seen with a higher dose (1 g) ofoestradiol; the cytosol receptor concentration falls rapidly, the minimum value being reached within 30min (De Sombre, 1970) . The present work aimed to study in quantitative terms the receptor distribution between the cytosol and nuclear fractions of immature rat uterus after the administration of the higher (1 ug) dose of oestradiol and to re-examine under these circumstances the mechanism of restoration of the cytosol receptor concentration.
Materials and Methods Steroids
[2,4,6,7-3H]Oestradiol-17fi (10OCi/mmol) was obtained from The Radiochemical Centre, Amersham, Bucks., U.K.; unlabelled oestradiol-17,8 was a product of Roussel UCLAF, Romainville, France. Both chemicals were found to be chromatographically pure. Solutions of (3H]oestradiol were prepared and stored as described (Megter & Baulieu, 1972) ; solutions of oestradiol were prepared by diluting the stock solution (0.4mg/ml in ethanol) with the appropriate aqueous medium.
Animals
Female Wistar rats (22-23 days old) were used; they were injected with 1 or 0.1,pg of oestradiol in 0.5 ml of saline subcutaneously or intraperitoneally and killed by cervical dislocation at the time-intervals indicated. The uteri were removed immediately, cleaned of connective tissue and homogenized in a sucrose (250mM)-MgCI2 (3mM) medium by using a glass-glass Kontes homogenizer. The tissues and homogenates were kept at 2-40C. Three uteri were usually homogenized in 1 ml of medium.
Cellfractionation
The homogenates were centrifuged at 800g for 10min to yield the low-speed supematant fraction and the nuclear-myofibrilar pellet; the pellets were washed twice with 4ml of medium and then resuspended in 0.5 ml of the homogenizing medium. (b) Method (II). Alternatively, a method described previously (Mester et al., 1970) was used where the number of high-affinity oestrogen-binding sites was determined by a Scatchard (1949) plot analysis. Portions (0.1 ml) of the uterine supernatant preparation were incubated with [3H]oestradiol at various concentrations (0.2, 0.5, 1.0 and 2.OnM) for 30min at 30°C in a total voume of 0.2ml. Charcoal-dextran (0.5ml) was then added, the tubes were incubated subsequently for 10min at 30°C, centrifuged and the radioactivity of the supernatant was determined. The results were corrected for radioactivity not adsorbed by charcoal in the absence of the uterine supernatant and represented in terms of bound/unbound hormone against amount of bound hormone. The concentration ofreceptor binding sites participating in the equilibrium was indicated at the intersection ofthe resulting straight line with the abscissa. Feherty et al. (1970) showed that the technique yields identical results for both low-speed and high-speed cytosol uterine supernatant preparations.
Nuclear receptors. The binding capacity of nuclear preparations was determined essentially as described by Anderson et al. (1972) . Portions (0.2ml) of the resuspended nuclear fractions (usually containing 50-l100ug of DNA) were incubated in a total volume of 0.6ml containing [3H]oestradiol (13nM) with or without oestradiol (5pM) in the homogenizing medium for 30min at 37°C. The mixtures were then cooled, centrifuged (800g for 5min) and the pellets washed once with 4ml of 0.25% Triton X-100 in the homogenizing medium, twice with 4ml of the homogenizing medium and finally extracted by a single freezing and thawing in 0.5 ml of Tris buffer containing 0.5M-KCI. The extracts were centrifuged (1500g for 5min) and the radioactivity of the supernatants was determined; the residual pellets containing the hormone bound by the 'insoluble' oestrogen receptor were extracted with 1 ml of acetone, the extracts were dried and their radioactivity was measured. The number of the saturable oestrogen-binding sites was calculated in the same way as described above (method I) for the low-speed supernatant fractions.
The exchange technique in vitro for determination ofthe binding capacity ofthe nuclear preparation was confirmed in the cell-free reconstituted system (Fig.  1 Determination ofendogenous oestradiol The oestradiol concentration in the uterine lowspeed supernatant fraction was measured by mixing portions (0.1 ml) of the sample or of standard oestradiol solution (0-200pg) in buffer with [3H]-oestradiol (20pg in 0.1 ml of buffer), heating at 70°C (3 min) to inactivate the receptor molecules present and then carrying out a competitive binding procedure by using rabbit uterine cytosol as described previously (Mester et al., 1971) . When only the receptor-bound oestradiol was to be measured, the samples were treated first by the charcoal-dextran suspension for 10min at 30°C to eliminate the free Vol. 146 hormone as well as hormone bound by the lowaffinity binding sites. It has been demonstrated (Mester et al., 1970; Mester & Robertson, 1971 ) that the dissociation of oestradiol-receptor complex is negligible (< 5 %) within this period, whereas >90 % of the oestradiol bound at zero time to the lowaffinity sites is adsorbed by charcoal during the incubation at 30°C for 10min.
Protein-synthesizing activity
This was measured by injecting the rats intraperitoneally with 2,uCi of ['4C]leucine (4O0Ci/mmol) and measuring the 14C radioactivity in the trichloroacetic acid (5%, w/v) precipitates of the uterine cytosol fractions; the precipitates were washed with 5 % trichloroacetic acid and dissolved in NCS tissue solubilizer (Nuclear-Chicago Corp., Des Plaines, Ill., U.S.A.).
Radioactivity determinations
These were carried out in a Packard model 3310 liquid-scintillation spectrometer by using 0-0.5 ml of the same sample plus 10ml of Omnifluor (NEN Chemicals, Frankfurt, West Germany) solution (0.4%) in toluene (cf. Mester et al., 1970) . The efficiency of counting was approx. 45 % for 3H and approx. 80% for "4C. When necessary, corrections for quenching were made by using external or internal standards.
DNA contents
These were measured by the method of Burton (1956) .
Results

Distribution of oestrogen receptors in the uterus of control animals
The concentration of oestrogen receptor in the uterine low-speed supernatant fraction of 22-23-dayold rats as determined by both methods (I) and (II) was approx. 3.5 fmol/ccg of DNA (approx. 0.9pmol/ uterus), in good agreement with previous reports (e.g. Gorski et al., 1970; Feherty et al., 1970 Under the cell-free reconstituted conditions the relative proportions of the 0.5M-KCl-extractable and residual receptors were dependent on the length of incubation. The nuclear uptake of [3H]oestradiol (presumably together with the receptor) in the presence of the uterine supernatant fraction was rapid into the soluble form, reaching a maximum value (approx. 0.4fmol/pg of DNA) within 5min with a subsequent decrease (approx. 60% of the 5min concentration remaining at 60min), whereas the concentration of the bound hormone in the insoluble nuclear fraction approached a maximum (approx. 1.Sfmol/pg of DNA) value only between 30 and 60 min (Fig. 2) .
Effect of oestradiol administration on the receptor distribution Both methods (I) and (II) showed approx. 90% decrease in the concentration of cytosol oestrogenbinding sites within 0.5h after the hormone (1,ug) administration (Fig. 3a) . At the same time, the concentration of soluble nuclear receptor rose to approx. 0.4fmol of oestrogen-binding sites/p,g of DNA (12% of the initial cytoplasmic receptor content) and that of the insoluble nuclear receptor to approx. 1.2fmol of oestrogen-binding sites/,g of DNA (35 % of the initial receptor content). The net increase in the total nuclear receptor content accounted, however, only for approx. 50 % of the loss of initial cytosol receptor content.
Since the method used to determine the cytosol receptor does not account for the occupied binding sites, the possibility that the missing receptor was present in the cytoplasm in the form of a complex with the hormone was examined. The concentration of total oestradiol in the low-speed supernatant fraction (related to the number of oestradiol molecules/cell) reached approx. 115 % of the initial supernatant receptor content at 0.5h after the hormone administration (assuming one binding site of the receptor equivalent to one oestradiol molecule). However, when the oestradiol determination was performed on the charcoal-treated (10min at 30°C) low-speed supernatant fraction, no detectable oestradiol was found in the supernatant indicating that the contribution of the receptor-bound oestradiol to the total supernatant oestradiol concentration was unmeasurably low under the conditions used [i.e. <10% of the total oestradiol (corresponding to approx. Spg of oestradiol in the assay tubes, which is the limit ofthe sensitivity ofthe method)].
The nuclear oestrogen receptor concentration decreased during the period between 0.5h and 7.5h after the oestradiol injection with the apparent halflife of approx. 140min for the soluble and approx. 200min for the insoluble fraction (Fig. 3b) . The cytosol oestradiol concentration decreased at a similarratewhereas the cytosol receptor concentration rose to approx. 60% of its initial value by 7.5 h.
Cytosol receptor replenishment after oestradiol (1,ug) injection
To distinguish whether the re-increase in the cytosol oestrogen-binding sites concentration within the first few hours after oestradiol administration is due to a process such as, e.g., activation or unmasking of the binding sites or to a synthesis of new 'receptor' molecules, rats were injected with oestradiol (1 pg) and 0.5 or 6h after with cycloheximide at an amount known to block the protein synthesis (200,ug/rat; cf. Sarff & Gorski, 1971 (Fig. 4) showed that although protein synthesis was inhibited to at least 80% (degree of inhibition during 1 h before killing the animals) by the cycloheximide, there was no significant difference between cycloheximide-injected (43 ± 10 % S.D. of the initial content of cytosol oestrogen-binding sites) and control (i.e. only oestradiol-injected) animals (48± 11 % S.D. of the initial content of cytosol oestrogenbinding sites) in terms of cytosol oestrogen-binding sites recovery 6h after the oestradiol administration. However, a large difference was observed in the concentration of cytosol oestrogen-binding sites between the cycloheximide-injected and control (only oestradiol-injected) rats when the drug was given 6h after the hormone and the animals were killed 5h later (11 h after oestradiol treatment). Cycloheximide when injected 0.5 h after oestradiol treatment was only slightly more efficient in inhibiting the oestrogen-binding-site replenishment by 11 h than when injected at 6h. The same results were obtained when the hormone was injected intraperitoneally instead of subcutaneously. The results were confirmed in repeated experiments (results not shown).
Cytosol-receptor variations after injection of 0.1 pg of oestradiol Since the above results did not agree with the pattern of the supernatant receptor replenishment Vol. 146 described by Sarff & Gorski (1971) , the relevant part of their experiments was repeated by injecting 0.1 pug of oestradiol intraperitoneally into 22-23-dayold rats.
Again (Fig. 5) , cycloheximide given 6h after oestradiol, inhibited the oestrogen-receptor replenishment between 6 and 12h after the hormone injection. In agreement with Sarff & Gorski (1971) a lower concentration of oestrogen-binding sites was detected in animals already given the drug at 0.5h after the hormone, compared with those only given cycloheximide 6h after oestradiol administration; however, this difference was much smaller than that reported by these authors. Again, repeated experiments (results not shown) gave similar results.
Discussion
Administration of a high dose (1 pig/rat) of oestradiol led to a rapid disappearance of a large proportion ofthe oestrogen receptor from the uterine cytoplasmic fraction. Only about one-half of the receptor lost from the cytoplasm could be recovered in the nuclear pellet by the exchange method (Anderson et al., 1972 The rats (two to three/group) were injected intraperitoneally with 0.1,pg of oestradiol in 0.5ml of saline and killed at the times indicated. Each uterus was homogenized in 0.6ml of the homogenizing medium, and the cytoplasmic receptor concentrations in individual uteri were determined by the Scatchard (1949) (1972) .
Experiments involving the use of a proteinsynthesis inhibitor (cycloheximide) led us to reconsider the sequence proposed by Sarff & Gorski (1971) for cytoplasmic receptor replenishment after oestradiol injection, according to which the entire synthesis of the new 'receptor' molecules occurs within the first 6h and the subsequent increase in oestrogen-binding capacity is due to 'activation' independent of continuing protein synthesis. In the present experiments, at 6h after administration of 1 jug of oestradiol/rat, approx. 50 % of the initial content of free cytosol oestrogen-binding sites were recovered in the cytoplasm by a process that may involve their reactivation and/or unmasking and that is not blocked by cycloheximide. The second stage of replenishment from 6h onwards was at least partly dependent on continuing protein synthesis. When the injected dose of oestradiol was only 0.1 jpg, a substantial part of the cytoplasmic receptor increase observed between 4 and 12h after was still inhibited by cycloheximide given 6h after oestradiol treatment, and was therefore presumably due to protein synthesis, although a smaller contribution of the 'activation' of pre-formed 'receptor' molecules cannot be excluded.
Quantitative comparison of the maximum concentration of nuclear oestrogen-binding sites reported here with those found under similar circumstances by Anderson et al. (1972) shows that their values are approximately three times higher. In view of the fact that the above authors suggest an increase 1975 in nuclear-binding capacity after oestradiol injection (maximum value approx. 1.5pmol/uterus) that exceeds by approx. 65% the total cytosol receptorbinding capacity (approx. 0.9pmol/uterus) of the non-injected rat uterus (see, e.g. Gorski et al., 1970) , the lower estimates appear more likely to be valid. In agreement with Anderson et al. (1972) , the presence of oestrogen receptors in the nuclear fraction of immature non-oestrogen-treated rat uterus has been observed. This result may be due to the presence of endogenous oestrogens (MeijsRoelofs etal., 1973) , or to a contamination by a small portion (approx. 10%) of the cytoplasmic receptor, e.g. during homogenization. An interesting phenomenon observed in the experiments in vivo was the apparent coexistence of free oestrogen-binding sites and unbound oestradiol in the supernatant fraction whereas a receptoroestradiol complex could not be detected; however, the free oestradiol pool may be partly or entirely extracellular.
The nuclear oestrogen receptors studied in this work were of two categories: the KCl-extractable form and the residual form. Most work up to now has been concerned with the KCl-extractable nuclear oestrogen receptors, although a certain amount of the high-affinity bound oestrogen has always remained in the residual pellet depending on the conditions of extraction. The presence of a distinct non-KCl-extractable fraction of bound oestrogen in rat uterine nuclei has been reported by De Hertogh et al. (1973) ; a similar 'non-soluble' residual oestrogen receptor from chick liver nuclei was studied in detail by Lebeau et al. (1973 Lebeau et al. ( , 1974 . The experimental evidence suggests that in vivo there may exist an equilibrium between the two forms of the receptor that reflects the (always arbitrary) extraction conditions. The possibility of interconversion of the two forms ofthe receptor is suggested by the variations of their relative concentrations under conditions both in vitro and in vivo.
